2016 Q1 Form 10-Q Financial Statement

#000114420416098115 Filed on May 02, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q4 2015 Q1
Revenue $1.105M $1.150M $911.8K
YoY Change 21.15% 27.78% 49.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $230.0K $340.0K $250.0K
YoY Change -8.0% 6.25% 38.89%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $862.00 $10.00K $1.591K
YoY Change -45.82%
% of Gross Profit
Operating Expenses $230.0K $340.0K $260.0K
YoY Change -11.54% 6.25% 52.94%
Operating Profit $695.8K $475.6K
YoY Change 46.31% 50.32%
Interest Expense -$180.0K -$200.0K -$180.0K
YoY Change 0.0% 11.11% 50.0%
% of Operating Profit -25.87% -37.85%
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0%
Pretax Income $700.0K $590.0K $475.6K
YoY Change 47.18% 47.5% 47.12%
Income Tax $508.00 $0.00 $0.00
% Of Pretax Income 0.07% 0.0% 0.0%
Net Earnings $695.3K $590.0K $475.6K
YoY Change 46.2% 47.5% 128.36%
Net Earnings / Revenue 62.95% 51.3% 52.16%
Basic Earnings Per Share $0.10 $0.08
Diluted Earnings Per Share $0.10 $81.49K $0.08
COMMON SHARES
Basic Shares Outstanding 7.264M shares 7.231M shares 6.088M shares
Diluted Shares Outstanding 7.292M shares 6.129M shares

Balance Sheet

Concept 2016 Q1 2015 Q4 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.00K $110.0K $260.0K
YoY Change -76.92% 120.0%
Cash & Equivalents $60.00K $106.8K $256.3K
Short-Term Investments
Other Short-Term Assets $510.0K $32.87K $52.30K
YoY Change 875.07% 21.74% 52.53%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $20.36M $20.72M $17.53M
YoY Change 16.12% 6.66% 37.63%
LONG-TERM ASSETS
Property, Plant & Equipment $8.947K $8.771K $17.50K
YoY Change -48.87% -54.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $50.00K $50.00K $70.00K
YoY Change -28.57% -28.57% -66.67%
Other Assets $320.0K $170.0K $12.50K
YoY Change 2460.0% -28.57%
Total Long-Term Assets $9.970M $10.94M $6.976M
YoY Change 42.92% 117.94% 111.72%
TOTAL ASSETS
Total Short-Term Assets $20.36M $20.72M $17.53M
Total Long-Term Assets $9.970M $10.94M $6.976M
Total Assets $30.33M $31.66M $24.51M
YoY Change 23.74% 29.5% 52.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $130.0K $100.0K $70.00K
YoY Change 85.71% -37.5% 250.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $860.6K $1.096M $1.096M
YoY Change -21.45% -55.63% -16.96%
Long-Term Debt Due $10.65M $11.82M $9.320M
YoY Change 14.27% 53.51% 75.85%
Total Short-Term Liabilities $11.89M $13.91M $10.64M
YoY Change 11.73% 31.53% 52.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $11.89M $13.91M $10.64M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $11.89M $13.91M $10.64M
YoY Change 11.75% 31.51% 52.65%
SHAREHOLDERS EQUITY
Retained Earnings $299.6K -$395.7K
YoY Change -449.11%
Common Stock $18.51M $18.51M
YoY Change 31.05%
Preferred Stock
YoY Change
Treasury Stock (at cost) $369.3K $369.3K
YoY Change 0.0%
Treasury Stock Shares 177.0K shares 177.0K shares 177.0K shares
Shareholders Equity $18.44M $17.74M $13.87M
YoY Change
Total Liabilities & Shareholders Equity $30.33M $31.66M $24.51M
YoY Change 23.74% 29.5% 52.85%

Cashflow Statement

Concept 2016 Q1 2015 Q4 2015 Q1
OPERATING ACTIVITIES
Net Income $695.3K $590.0K $475.6K
YoY Change 46.2% 47.5% 128.36%
Depreciation, Depletion And Amortization $862.00 $10.00K $1.591K
YoY Change -45.82%
Cash From Operating Activities $710.0K $620.0K $280.0K
YoY Change 153.57% 24.0% -1033.33%
INVESTING ACTIVITIES
Capital Expenditures $1.038K -$10.00K $0.00
YoY Change -50.0%
Acquisitions
YoY Change
Other Investing Activities $1.900M -$1.760M $270.0K
YoY Change 603.7% 100.0% -130.68%
Cash From Investing Activities $1.890M -$1.760M $270.0K
YoY Change 600.0% 95.56% -130.68%
FINANCING ACTIVITIES
Cash Dividend Paid $617.4K $486.7K
YoY Change 26.86% 1043.5%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.650M 1.190M -340.0K
YoY Change 679.41% 197.5% 209.09%
NET CHANGE
Cash From Operating Activities 710.0K 620.0K 280.0K
Cash From Investing Activities 1.890M -1.760M 270.0K
Cash From Financing Activities -2.650M 1.190M -340.0K
Net Change In Cash -50.00K 50.00K 210.0K
YoY Change -123.81% -85899345920001900.0% -120.59%
FREE CASH FLOW
Cash From Operating Activities $710.0K $620.0K $280.0K
Capital Expenditures $1.038K -$10.00K $0.00
Free Cash Flow $709.0K $630.0K $280.0K
YoY Change 153.2% 21.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
271520 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1894452 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7260 USD
CY2016Q1 loan Long Term Loans Receivable
LongTermLoansReceivable
9591050 USD
CY2015Q4 loan Long Term Loans Receivable
LongTermLoansReceivable
10705040 USD
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8947 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8771 USD
CY2016Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
315581 USD
CY2015Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
164510 USD
CY2016Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
127777 USD
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
99643 USD
CY2016Q1 loan Deferred Origination Fees
DeferredOriginationFees
249258 USD
CY2015Q4 loan Deferred Origination Fees
DeferredOriginationFees
279682 USD
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11888153 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13913487 USD
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
7441 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
7441 USD
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
18503921 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
18500524 USD
CY2016Q1 us-gaap Treasury Stock Value
TreasuryStockValue
369335 USD
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
369335 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
299618 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-395707 USD
CY2016Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
177000 shares
CY2016Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
0 USD
CY2015Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
486695 USD
CY2016Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
617443 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-340291 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2651045 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
208606 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-45557 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47676 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
256282 USD
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7441039 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7264039 shares
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
508 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
179637 USD
CY2016Q1 us-gaap Interest Paid
InterestPaid
176799 USD
CY2015Q1 us-gaap Depreciation
Depreciation
1591 USD
CY2016Q1 us-gaap Depreciation
Depreciation
862 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1038 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2016Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-1405601 USD
CY2015Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1616046 USD
CY2016Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount Commercial
LoansAndLeasesReceivableGrossCarryingAmountCommercial
29008550 USD
CY2015Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount Commercial
LoansAndLeasesReceivableGrossCarryingAmountCommercial
23760956 USD
CY2016Q1 loan Jointly Funded Loans Total
JointlyFundedLoansTotal
1835000 USD
CY2016Q1 loan Jointly Funded Loans
JointlyFundedLoans
1230000 USD
CY2015Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
1000000 USD
CY2014Q3 loan Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
87719 shares
CY2014Q3 loan Warrants Exercise Price
WarrantsExercisePrice
3.5625
CY2014Q3 loan Warrants Expiry Date
WarrantsExpiryDate
2019-07-28
CY2015Q2 loan Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
50750 shares
CY2015Q2 loan Warrants Exercise Price
WarrantsExercisePrice
5.4875
CY2015Q2 loan Warrants Expiry Date
WarrantsExpiryDate
2020-05-22
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
17550 shares
CY2014Q3 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
42224 USD
CY2015Q2 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
54928 USD
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
MANHATTAN BRIDGE CAPITAL, INC
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001080340
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q1 dei Trading Symbol
TradingSymbol
LOAN
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7271289 shares
CY2016Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
464889 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2016Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q3 loan Fair Value Of Restricted Shares Granted
FairValueOfRestrictedSharesGranted
195968 USD
CY2016Q1 loan Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights For Employee And Nonemployee Directors
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsForEmployeeAndNonemployeeDirectors
Historically, until the year ended December 31, 2014, each non-employee director of the Company was granted an option for 7,000 common shares upon first taking office, and received an annual option grant for an additional 7,000 common shares for each additional year in office. Generally, options outstanding vest over periods not exceeding four years and are exercisable for up to five years from the grant date.
CY2016Q1 loan Cash Restricted For Reduction Of Line Of Credit
CashRestrictedForReductionOfLineOfCredit
464889 USD
CY2015Q1 loan Cash Restricted For Reduction Of Line Of Credit
CashRestrictedForReductionOfLineOfCredit
0 USD
CY2016Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
CY2015Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
1373846 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
695832 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
475596 USD
CY2015Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
12500 USD
CY2016Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
28333 shares
CY2015Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
41485 shares
CY2016Q1 loan Share Based Compensation Expense
ShareBasedCompensationExpense
3397 USD
CY2015Q1 loan Share Based Compensation Expense
ShareBasedCompensationExpense
3416 USD
CY2011Q3 loan Fair Value Of Restricted Shares Amortization Period
FairValueOfRestrictedSharesAmortizationPeriod
P15Y
CY2011 loan Operating Lease Term Of Lease
OperatingLeaseTermOfLease
five years and two months
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
18441645 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
17742923 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30329798 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31656410 USD
CY2016Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2015Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
617443 USD
CY2016Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
860620 USD
CY2015Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1095620 USD
CY2016Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
10650498 USD
CY2015Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
11821099 USD
CY2016Q1 loan Interest Income From Loans
InterestIncomeFromLoans
914309 USD
CY2015Q1 loan Interest Income From Loans
InterestIncomeFromLoans
756750 USD
CY2016Q1 loan Origination Fees
OriginationFees
190281 USD
CY2015Q1 loan Origination Fees
OriginationFees
155011 USD
CY2016Q1 us-gaap Revenues
Revenues
1104590 USD
CY2015Q1 us-gaap Revenues
Revenues
911761 USD
CY2016Q1 loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
179550 USD
CY2015Q1 loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
183055 USD
CY2016Q1 loan Referral Fees
ReferralFees
1369 USD
CY2015Q1 loan Referral Fees
ReferralFees
1197 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
227839 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
251913 USD
CY2016Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
408758 USD
CY2015Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
436165 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
508 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
695324 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
475596 USD
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7264039 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6087531 shares
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7292372 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6129016 shares
CY2015Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3418 USD
CY2016Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
12041 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3416 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3397 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
5532 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-17764 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
25309 USD
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
16063 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-97560 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
28135 USD
CY2015Q1 loan Increase Decrease In Deferred Origination Fees
IncreaseDecreaseInDeferredOriginationFees
78243 USD
CY2016Q1 loan Increase Decrease In Deferred Origination Fees
IncreaseDecreaseInDeferredOriginationFees
30424 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
277377 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
711036 USD
CY2015Q1 loan Issuance Of Short Term Loans
IssuanceOfShortTermLoans
2807000 USD
CY2016Q1 loan Issuance Of Short Term Loans
IssuanceOfShortTermLoans
5913500 USD
CY2015Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
3078520 USD
CY2016Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
7808990 USD

Files In Submission

Name View Source Status
0001144204-16-098115-index-headers.html Edgar Link pending
0001144204-16-098115-index.html Edgar Link pending
0001144204-16-098115.txt Edgar Link pending
0001144204-16-098115-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
loan-20160331.xml Edgar Link completed
loan-20160331.xsd Edgar Link pending
loan-20160331_cal.xml Edgar Link unprocessable
loan-20160331_def.xml Edgar Link unprocessable
loan-20160331_lab.xml Edgar Link unprocessable
loan-20160331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v437791_10q.htm Edgar Link pending
v437791_ex10-5.htm Edgar Link pending
v437791_ex31-1.htm Edgar Link pending
v437791_ex31-2.htm Edgar Link pending
v437791_ex32-1.htm Edgar Link pending
v437791_ex32-2.htm Edgar Link pending